Datavault AI (NASDAQ: DVLT) has expanded its definitive licensing agreement with DataMeds AI Inc., extending its PharmacyChain blockchain-related technology beyond pharmaceutical distribution into commercial healthcare, healthspan, and wellness applications. The amended agreement, announced on July 30, 2026, is designed to support patient-controlled health data access, monetization, and real-world asset tokenization across pharmacy, medical, laboratory, and wearable device environments. This expansion leverages a behavioral healthcare patent portfolio focused on medical logistics, IoT population health, and AI-driven remote patient monitoring.
Under the terms of the amended agreement, Datavault AI will receive common shares representing approximately 19.9% of DataMEDS’ outstanding common stock upon closing of previously announced related transactions. This replaces the preferred shares originally contemplated for tax optimization purposes. The companies stated that the agreement accelerates deployment of Datavault AI’s technology into the healthcare sector, targeting opportunities within the rapidly expanding global health and wellness market while enabling new patient-controlled data transaction models.
The implications of this move are significant for the healthcare industry. By integrating blockchain technology with AI-driven data solutions, the partnership aims to give patients greater control over their health data, potentially transforming how medical information is shared and monetized. This could lead to more personalized healthcare experiences and new revenue streams for patients who choose to share their data. For the industry, it represents a step toward decentralized health data management, which may improve data security and interoperability across different healthcare providers and devices.
Datavault AI’s technology suite includes its Acoustic Sciences division, featuring WiSA, ADIO, and Sumerian patented technologies for wireless high-definition sound transmission, and its Data Science division, which leverages Web 3.0 and high-performance computing for data perception, valuation, and secure monetization. The company’s platform serves multiple industries, including biotech, fintech, real estate, and healthcare, and its Information Data Exchange enables Digital Twins and secure licensing of name, image, and likeness by attaching physical real-world objects to immutable metadata.
For more details on the expanded agreement, the full press release is available at https://ibn.fm/vBAxH. Additional updates regarding Datavault AI can be found in the company’s newsroom at https://ibn.fm/DVLT.
